GSK plc’s IDEAYA Biosciences IDYA Stock Holding History

GSK plc’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.7M	Hold	1,333,333	–	–	8.25%	5
2026 Q1	$44.4M	Hold	1,333,333	–	–	7.41%	5
2025 Q4	$46.1M	Buy	+1,333,333	New	+$42.5M	5.77%	6

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

GSK plc's IDYA Position: Q2 2026 in Review

GSK plc held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 1,333,333 shares worth $49.7M. The position accounts for 8.25% of the portfolio, ranked #5.

GSK plc first reported a position in IDYA in Q4 2025 and has held it in 3 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

GSK plc held 1,333,333 shares of IDEAYA Biosciences worth $49.7M as of Q2 2026.
GSK plc left its IDEAYA Biosciences share count unchanged in Q2 2026.
IDEAYA Biosciences made up 8.25% of GSK plc's portfolio in Q2 2026, its #5 holding.
GSK plc first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 3 quarters since.
284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on GSK plc's 13F filing for Q2 2026, filed 13 Aug 2026.